CLEAN VALIDATED · MANUAL WIPE CLEANING · v2.1

What manual wipe cleaning results actually demonstrate

Clean Validated | Article 1 of 5 | Version 2.1 | 27 October 2026

A low result after wiping is useful only when the measured endpoint matches the decision. In pharmaceutical manufacturing, chemical residue removal, microbial inactivation and control of transfer require separate evidence. A culture-negative result does not establish removal of an API, protein or endotoxin. A visually clean surface does not establish an acceptable carryover level.

The distinction changes how a team develops a cleaning instruction. Start with the residue or organism and the surface on which it matters. Then decide what must be measured and how the wipe could move contamination to another location.

Separate location from biological activity

Physical removal moves material away from the original surface. Inactivation reduces biological activity under the conditions of the assay. Transfer places material on the wipe, a glove or a receiving surface. A single wiping operation may do all three. A source-surface reduction cannot identify their relative contributions unless the study measures the relevant compartments [5,6,7].

In a healthcare-surface model, wipes transferred C. difficile spores from an inoculated area to previously uncontaminated areas and retained spores after wiping [5]. That result does not set a pharmaceutical maximum area per wipe. It identifies a failure route that a site should consider when defining exchange rules and zone boundaries.

Removal changes location. Inactivation changes biological activity. Secondary transfer needs a separate observation. 02 MECHANISMS Follow both the material and the activity LOCATION Source surface What remains after treatment? LOCATION Used wipe What was collected and retained? LOCATION Receiving surface What was deposited elsewhere? Inactivation can occur in each compartment. A low source result alone cannot identify the mechanism or exclude transfer. Clean Validated | Original schematic | v2.0 | 26 October 2026
Figure 1. Removal changes location. Inactivation changes biological activity. Secondary transfer needs a separate observation.

Choose the endpoint for the hazard

Cell-processing research makes the distinction concrete. In a stainless-steel model, some cleaning conditions left no detectable cells while proteins or DNA remained [3]. A separate study found different outcomes for mycoplasma, a virus model and endotoxin [4]. These papers support residue-specific questions rather than a single claim that a cabinet is clean.

The assay matters as much as the target. Culture reports viable organisms recovered under defined conditions. PCR reports a nucleic-acid signal. ATP is a broad biological-residue indicator. TOC reports organic carbon without identifying its source. Specific chemical methods can answer a residue question only within their demonstrated specificity, recovery and reporting range.

Faircloth and colleagues used RNase RT-qPCR for human noroviruses and an infectivity assay for Tulane virus [8]. Those outcomes should retain their different labels when the paper is cited. A favourable molecular result is not automatically an infectivity result for the same human virus.

Read the full result rather than the strongest phrase

The 2026 sensor-assisted BSC paper is useful for observing coverage and mechanical engagement. Its abstract describes complete growth inhibition with combined treatment, while the detailed results and discussion include residual colonies in some combined-treatment tests [2]. The accurate conclusion is a reduction in viable recovery, including some non-detects. The paper does not establish uniform clearance, a universal pressure threshold or intrinsic alcohol sporicidal activity.

Turn the distinction into a study question

For a product-contact panel, the question may be whether a specified API and cleaning-agent residue remain below justified limits. For a cleanroom surface, cleaning may precede a separately qualified disinfection sequence. For a cabinet changeover, protein, nucleic-acid, microbial and endotoxin questions may each need an endpoint. The task determines the evidence.

Record the intended claim before selecting the wipe. Identify the source, relevant receiving surfaces, the used-wipe route and the waste pathway. Decide whether transfer has a meaningful consequence for the next product or zone. Use a separate sampling method with demonstrated recovery and controls. A low analytical value is meaningful only when the method can support the required decision [1,9].

Apply it to the next review

Ask which hazard is controlled, which endpoint measures it, what could be transferred, and what the result cannot establish. Use T01 to record the intended process and T05 to define the sampling locations. The whitepaper provides the complete evidence synthesis and the limitations of each study.

Continue with the series

Series introduction · Full whitepaper · Working toolkit. Next article: How to define an observable manual wiping technique (scheduled 10 November 2026, 10:00 CET).

This article supports development and review. Apply approved site procedures for operational work. Original corpus cutoff 17 October 2026; targeted source check 26 October 2026.

Sources

Reference numbers are local to this publication. The whitepaper has a separate master bibliography.

[1] EU GMP Annex 15: Qualification and Validation (2015). https://health.ec.europa.eu/system/files/2016-11/2015-10_annex15_0.pdf

[2] Mizuno M, Kishino Y, Shirai Y, Matsuda J, Sekiya I. (2026). Biosafety-cabinet wipe-cleaning assessment system: Integration of visual, thermal, and pressure sensing. Regenerative therapy. https://doi.org/10.1016/j.reth.2026.101151. Full text checked.

[3] Mizuno M, Yori K, Takeuchi T, Yamamoto T, Ishikawa N, Kobayashi M, Nishio M, Sekiya I. (2024). Evaluation of cleaning methods for change-over after the processing of cell products to avoid cross-contamination risk. Regenerative therapy. https://doi.org/10.1016/j.reth.2024.07.002. Full text checked.

[4] Mizuno M, Kimbara S, Ichise H, Ishikawa N, Nishihara Y, Nishio M, Sekiya I. (2025). Cleaning methods for biosafety cabinet to eliminate residual mycoplasmas, viruses, and endotoxins after changeover. Regenerative therapy. https://doi.org/10.1016/j.reth.2024.11.020. Full text checked.

[5] Nkemngong CA, Chaggar GK, Li X, Teska PJ, Oliver HF. (2020). Disinfectant wipes transfer Clostridioides difficile spores from contaminated surfaces to uncontaminated surfaces during the disinfection process. Antimicrobial resistance and infection control. https://doi.org/10.1186/s13756-020-00844-0. Full text checked.

[6] Cutts TA, Robertson C, Theriault SS, Nims RW, Kasloff SB, Rubino JR, Ijaz MK. (2020). Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked Wipes. Frontiers in public health. https://doi.org/10.3389/fpubh.2020.00183. Full text checked.

[7] Cutts TA, Kasloff SB, Krishnan J, Nims RW, Theriault SS, Rubino JR, Ijaz MK. (2021). Comparison of the Efficacy of Disinfectant Pre-impregnated Wipes for Decontaminating Stainless Steel Carriers Experimentally Inoculated With Ebola Virus and Vesicular Stomatitis Virus. Frontiers in public health. https://doi.org/10.3389/fpubh.2021.657443. Full text checked.

[8] Faircloth J, Goulter RM, Manuel CS, Arbogast JW, Escudero-Abarca B, Jaykus LA. (2022). The Efficacy of Commercial Surface Sanitizers against Norovirus on Formica Surfaces with and without Inclusion of a Wiping Step. Applied and environmental microbiology. https://doi.org/10.1128/aem.00807-22. Full text checked.

[9] van den Berg RB, Korczowska E, Santos MSF, Portilha-Cunha MF, Ribeiro ARL, Bláhová L, Bláha L, Eyser CV, Tuerk J, van Rossen RCJM, Wilms EB, Crul M. (2025). Surface Wipe Sampling of Hazardous Medicinal Products: A European Interlaboratory Comparison Study. Drug testing and analysis. https://doi.org/10.1002/dta.3902. Full text checked.